دورية أكاديمية

Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents.

التفاصيل البيبلوغرافية
العنوان: Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents.
المؤلفون: Boraey NF; Department of Pediatrics, Faculty of Medicine, Sohag University, Sohag, Egypt., Bebars MA; Department of Pediatrics, Princess Alexandra hospital, Harlow, UK., Wahba AA; Department of Pediatrics at SSMC (Sheikh Shakhbout Medical City, Abu Dhabi, UAE., Abd El Lateef HM; Department of Pediatrics, Faculty of Medicine, Ain-Shams University, Cairo, Egypt., Attia MA; Department of Pediatrics at SKMC (Sheikh khalifa Medical City, Abu Dhabi, UAE., Elsayed AH; Department of Pediatrics, Faculty of Medicine for Boys, Al-Azhar University, Al-Azhar, Egypt., Rashed KA; Department of Pediatrics, Faculty of Medicine for Boys, Al-Azhar University, Al-Azhar, Egypt., Sorour EI; Department of Pediatrics, Faculty of Medicine for Boys, Al-Azhar University, Al-Azhar, Egypt., Ahmed MF; Department of Pediatrics, Faculty of Medicine for Boys, Al-Azhar University, Al-Azhar, Egypt., Abd-Elrehim GAB; Department of Pediatrics, Faculty of Medicine, Sohag University, Sohag, Egypt., Soliman AA; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Shehab MMM; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Elhindawy EM; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Ibraheem AAA; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Shehata H; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Yousif YM; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Hashem MIA; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Ahmed AA; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Emam AA; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt. ahmedemam1111@yahoo.com., Gameil DM; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Abdelhady EM; Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Abdelkhalek K; Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt., Morsi WEMA; Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt., Selim DM; Department of Pediatrics, Faculty of Medicine, Ain-Shams University, Cairo, Egypt., Razek SA; Department of Pediatrics, Faculty of Medicine, Ain-Shams University, Cairo, Egypt., Ashraf B; Department of Otorhinolaryngology, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Saleh ASE; Department of Otorhinolaryngology, Faculty of Medicine, Benha University, Benha, Egypt., Eltrawy HH; Department of Chest diseases, Faculty of Medicine for Girls, Al-Azhar University, Al-Azhar, Egypt., Alanwar MI; Department of Cardiothoracic surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Fouad RA; Department of Medical Biochemistry, College of Medicine, AlMaarefa University, Riyadh, Saudi Arabia.; Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Omar WE; Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Nabil RM; Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Abdelhamed MR; Department of Clinical pathology, Faculty of Medicine for Boys, Al-Azhar University, Al-Azhar, Egypt., Ibrahim MY; Department of Clinical pathology, Faculty of Medicine for Girls, Al-Azhar University, Al-Azhar, Egypt., Malek MM; Department of Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Afify MR; Department of Medical microbiology and Parasitology. Faculty of Medicine, University of Jeddah, Jeddah, 21589, Saudi Arabia., Alharbi MT; Department of Medical microbiology and Parasitology. Faculty of Medicine, University of Jeddah, Jeddah, 21589, Saudi Arabia., Nagshabandi MK; Department of Medical microbiology and Parasitology. Faculty of Medicine, University of Jeddah, Jeddah, 21589, Saudi Arabia., Tarabulsi MK; Department of Medical microbiology and Parasitology. Faculty of Medicine, University of Jeddah, Jeddah, 21589, Saudi Arabia., Qashqary ME; Department of Family and community medicine, University Medical Center, University of Jeddah, Jeddah, Saudi Arabia., Almoraie LM; Department of Family and community medicine, University Medical Center, University of Jeddah, Jeddah, Saudi Arabia., Salem HF; Department of Anesthesia, Faculty of Medicine, Benha University, Banha, Egypt., Rashad MM; Department of Anesthesia, Faculty of Medicine, Zagazig University, Zagazig, Egypt., El-Gaaly SAA; Department of Internal Medicine, Faculty of Medicine, Ain-Shams University, Ain-Shams, Egypt., El-Deeb NA; Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Abdallah AM; Department of Family Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Fakhreldin AR; Department of Pediatrics, Faculty of Medicine, Aswan University, Aswan, Egypt., Hassouba M; Department of Pediatrics, SUNY Downstate Health Science University, Kings County Hospital, Brooklyn, NY, USA., Massoud YM; Department of Tropical Medicine, Faculty of Medicine, Ain-Shams University, Ain-Shams, Egypt., Attaya MSM; Department of Pediatrics, Faculty of Medicine for Girls, Al-Azhar University, Al-Azhar, Egypt., Haridi MK; Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt.
المصدر: Pediatric research [Pediatr Res] 2024 Jan 04. Date of Electronic Publication: 2024 Jan 04.
Publication Model: Ahead of Print
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 0100714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0447 (Electronic) Linking ISSN: 00313998 NLM ISO Abbreviation: Pediatr Res Subsets: MEDLINE
أسماء مطبوعة: Publication: 2012- : New York : Nature Publishing Group
Original Publication: Basel ; New York : Karger.
مستخلص: Background: Given the sparse data on the renin-angiotensin system (RAS) and its biological effector molecules ACE1 and ACE2 in pediatric COVID-19 cases, we investigated whether the ACE1 insertion/deletion (I/D) polymorphism could be a genetic marker for susceptibility to COVID-19 in Egyptian children and adolescents.
Methods: This was a case-control study included four hundred sixty patients diagnosed with COVID-19, and 460 well-matched healthy control children and adolescents. The I/D polymorphism (rs1799752) in the ACE1 gene was genotyped by polymerase chain reaction (PCR), meanwhile the ACE serum concentrations were assessed by ELISA.
Results: The ACE1 D/D genotype and Deletion allele were significantly more represented in patients with COVID-19 compared to the control group (55% vs. 28%; OR = 2.4; [95% CI: 1.46-3.95]; for the DD genotype; P = 0.002) and (68% vs. 52.5%; OR: 1.93; [95% CI: 1.49-2.5] for the D allele; P = 0.032). The presence of ACE1 D/D genotype was an independent risk factor for severe COVID-19 among studied patients (adjusted OR: 2.6; [95% CI: 1.6-9.7]; P < 0.001.
Conclusions: The ACE1 insertion/deletion polymorphism may confer susceptibility to SARS-CoV-2 infection in Egyptian children and adolescents.
Impact: Recent studies suggested a crucial role of renin-angiotensin system and its biological effector molecules ACE1 and ACE2 in the pathogenesis and progression of COVID-19. To our knowledge, ours is the first study to investigate the association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Caucasian children and adolescents. The presence of the ACE1 D/D genotype or ACE1 Deletion allele may confer susceptibility to SARS-CoV-2 infection and being associated with higher ACE serum levels; may constitute independent risk factors for severe COVID-19. The ACE1 I/D genotyping help design further clinical trials reconsidering RAS-pathway antagonists to achieve more efficient targeted therapies.
(© 2024. The Author(s).)
References: Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (Lond., Engl.) 395, 514–523 (2020). (PMID: 10.1016/S0140-6736(20)30154-9)
World Health Organization. WHO Coronavirus (COVID-19) Dashboard Available at: https://covid19.who.int .
Guo, C. X. et al. Epidemiological and clinical features of pediatric COVID-19. BMC Med. 18, 250 (2020). (PMID: 32762696740897510.1186/s12916-020-01719-2)
Götzinger, F. et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc. Health 4, 653–661 (2020). (PMID: 32593339731644710.1016/S2352-4642(20)30177-2)
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). (PMID: 32015507709541810.1038/s41586-020-2012-7)
Zou, X. et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14, 185–192 (2020). (PMID: 32170560708873810.1007/s11684-020-0754-0)
Kurdi, M., De Mello, W. C. & Booz, G. W. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int. J. Biochem. Cell Biol. 37, 1357–1367 (2005). (PMID: 1583326810.1016/j.biocel.2005.01.012)
Rodrigues Prestes, T. R., Rocha, N. P., Miranda, A. S., Teixeira, A. L. & Simoes-E-Silva, A. C. The anti-inflammatory potential of ACE2/Angiotensin-(1-7)/Mas receptor axis: evidence from basic and clinical research. Curr. Drug Targets 18, 1301–1313 (2017). (PMID: 2746934210.2174/1389450117666160727142401)
Bourgonje, A. R. et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J. Pathol. 251, 228–248 (2020). (PMID: 32418199727676710.1002/path.5471)
Kuba, K. et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875–879 (2005). (PMID: 16007097709578310.1038/nm1267)
Imai, Y. et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112–116 (2005). (PMID: 16001071709499810.1038/nature03712)
Sayed-Tabatabaei, F. A., Oostra, B. A., Isaacs, A., van Duijn, C. M. & Witteman, J. C. ACE polymorphisms. Circ. Res. 98, 1123–1133 (2006). (PMID: 1669089310.1161/01.RES.0000223145.74217.e7)
Rigat, B. et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Investig. 86, 1343–1346 (1990). (PMID: 197665529686810.1172/JCI114844)
Abouzeid, H. et al. Angiotensin-converting enzyme insertion/deletion gene polymorphism in Egyptian children with CAP: a case-control study. Pediatr. Pulmonol. 52, 1592–1598 (2017). (PMID: 2902816010.1002/ppul.23886)
Cruces, P. et al. Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS. Intensive Care Med. 38, 113–119 (2012). (PMID: 2200582510.1007/s00134-011-2381-3)
Harding, D. et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am. J. Respir. Crit. Care Med. 165, 1103–1106 (2002). (PMID: 1195605210.1164/ajrccm.165.8.2108089)
Dong, Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics 145, e20200702 (2020). (PMID: 3217966010.1542/peds.2020-0702)
Ferguson, N. D. et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 38, 1573–1582 (2012). (PMID: 2292665310.1007/s00134-012-2682-1)
Goldstein, B., Giroir, B. & Randolph, A., International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med. 6, 2–8 (2005). (PMID: 1563665110.1097/01.PCC.0000149131.72248.E6)
Shen, K. L. et al. Global Pediatric Pulmonology Alliance. Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition). World J. Pediatr. 16, 232–239 (2020). (PMID: 32333248718065310.1007/s12519-020-00362-4)
Karakus, N., Yigit, S., Kalkan, G. & Sezer, S. High association of angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism with recurrent aphthous stomatitis. Arch. Dermatol. Res. 305, 513–517 (2013). (PMID: 2345548710.1007/s00403-013-1333-x)
Park, E. Y., Ahn, H. M., Lee, J. A. & Hong, Y. M. Insertion/deletion polymorphism of angiotensin converting enzyme gene in Korean hypertensive adolescents. Heart Vessels 24, 193–198 (2009). (PMID: 1946652010.1007/s00380-008-1101-6)
Hammad, A. et al. Angiotensin-converting enzyme insertion/deletion gene polymorphism in Egyptian children with systemic lupus erythematosus: a possible relation to proliferative nephritis. Lupus 26, 762–767 (2017). (PMID: 2795658210.1177/0961203316682096)
Yang, H., Wang, Y., Liu, L. & Hu, Q. Increased susceptibility of sepsis associated with CD143 deletion/insertion polymorphism in Caucasians: a meta- analysis. Int. J. Clin. Exp. Pathol. 7, 6551–6558 (2014). (PMID: 254007334230104)
Delanghe, J. R., Speeckaert, M. M. & De Buyzere, M. L. COVID-19 infections are also affected by human ACE1 D/I polymorphism. Clin. Chem. Lab. Med. 58, 1125–1126 (2020). (PMID: 3228624610.1515/cclm-2020-0425)
de Souza, T. H., Nadal, J. A., Nogueira, R. J. N., Pereira, R. M. & Brandão, M. B. Clinical manifestations of children with COVID-19: a systematic review. Pediatr. Pulmonol. 55, 1892–1899 (2020). (PMID: 32492251730065910.1002/ppul.24885)
Pati, A., Mahto, H., Padhi, S. & Panda, A. K. ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: an epidemiological study in the Asian population. Clin. Chim. Acta 510, 455–458 (2020). (PMID: 32791137741613310.1016/j.cca.2020.08.008)
Yamamoto, N. et al. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype. Gene 758, 144944 (2020). (PMID: 32628976783392510.1016/j.gene.2020.144944)
Verma, S. et al. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients. Infect. Genet Evol. 91, 104801 (2021). (PMID: 33676010792978810.1016/j.meegid.2021.104801)
Zhang, H., Penninger, J. M., Li, Y., Zhong, N. & Slutsky, A. S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 46, 586–590 (2020). (PMID: 32125455707987910.1007/s00134-020-05985-9)
Elbasan, O. et al. Angiotensin-converting enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension. PloS One 18, e0288338 (2023). (PMID: 374329621033569010.1371/journal.pone.0288338)
Avanoglu Guler, A. et al. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease. Scand. J. Clin. Lab. Investig. 81, 160–165 (2021). (PMID: 10.1080/00365513.2021.1871641)
Ajala, A. R. et al. Association of ACE gene insertion/deletion polymorphism with birth weight, blood pressure levels, and ACE activity in healthy children. Am. J. Hypertens. 25, 827–832 (2012). (PMID: 2264778110.1038/ajh.2012.50)
Jacobsen, P. K. Preventing end stage renal disease in diabetic patients–genetic aspect (part I). J. Renin Angiotensin Aldosterone Syst. 6, 1–14 (2005). (PMID: 1608884610.3317/jraas.2005.001)
Mizuiri, S. et al. Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression. Kidney Int. 60, 1124–1130 (2001). (PMID: 1153210810.1046/j.1523-1755.2001.0600031124.x)
Itoyama, S. et al. ACE1 polymorphism and progression of SARS. Biochem. Biophys. Res. Commun. 323, 1124–1129 (2004). (PMID: 15381116709280610.1016/j.bbrc.2004.08.208)
Gómez, J. et al. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene 762, 145102 (2020). (PMID: 32882331745696610.1016/j.gene.2020.145102)
Li, X., Sun, X., Jin, L. & Xue, F. Worldwide spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis. Eur. J. Hum. Genet. 19, 1002–1008 (2011). (PMID: 21559052317936610.1038/ejhg.2011.66)
Aziz, M. A. & Islam, M. S. Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID-19: a meta-analysis. Mol. Genet. Genom. Med. 10, e2063 (2022). (PMID: 10.1002/mgg3.2063)
Tikellis, C., & Thomas, M. C. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int. J. Pept. 2012, 256294 (2012).
Gemmati, D. et al. COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? Int. J. Mol. Sci. 21, 3474 (2020). (PMID: 32423094727899110.3390/ijms21103474)
Karmouty-Quintana, H. et al. Emerging mechanisms of pulmonary vasoconstriction in SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) and potential therapeutic targets. Int. J. Mol. Sci. 21, 8081 (2020). (PMID: 33138181766260410.3390/ijms21218081)
Jin, H. Y. et al. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production. PloS One 7, e38502 (2012). (PMID: 22693641336791910.1371/journal.pone.0038502)
Shenoy, V. et al. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 182, 1065–1072 (2010). (PMID: 20581171297084710.1164/rccm.200912-1840OC)
Jarcho, J. A. et al. Inhibitors of the Renin-Angiotensin-Aldosterone system and Covid-19. N. Engl. J. Med. 382, 2462–2464 (2020). (PMID: 3235662510.1056/NEJMe2012924)
تواريخ الأحداث: Date Created: 20240104 Latest Revision: 20240104
رمز التحديث: 20240105
DOI: 10.1038/s41390-023-02982-8
PMID: 38177248
قاعدة البيانات: MEDLINE
الوصف
تدمد:1530-0447
DOI:10.1038/s41390-023-02982-8